← Eichor
Study identifier: NCT07456020 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Assessment of Consciousness With CRS-R and SECONDs

Condition: Disorders of Consciousness Due to Severe Brain Injury · Minimally Conscious State · Unresponsive Wakefulness Syndrome  ·  Sponsor: BDH-Klinik Hessisch Oldendorf

PhaseN/A
Planned participants110
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Accurately determining the level of consciousness in patients with severe brain injury is essential for treatment planning, prognosis, and ethical decision-making. Clinically, levels of consciousness are differentiated into coma, Unresponsive Wakefulness Syndrome (UWS), and Minimally Conscious State (MCS) based on behavioral signs. Although behavioral assessment is considered the clinical gold standard, it is prone to misclassification. Research has shown that a substantial proportion of patients initially diagnosed with UWS may actually show signs of minimal consciousness, which is associated with better cognitive abilities and a more favorable prognosis. The Coma Recovery Scale-Revised (CRS-R) is internationally recommended for diagnosing disorders of consciousness, but it is time-consuming and not free from diagnostic error. Repeated assessments can significantly improve diagnostic accuracy. To enhance feasibility in routine clinical practice, a shorter and more time-efficient assessment tool, the Simplified Evaluation of CONsciousness Disorders (SECONDs), was developed. This scale focuses on the behavioral signs most strongly associated with MCS and uses optimized testing procedures while maintaining high diagnostic accuracy. The aim of this study is to further evaluate diagnostic approaches for assessing consciousness in patients with severe brain injury and to improve the reliability and clinical applicability of these assessments.

This description comes directly from the study's public registry record.

Talk to the study team

Melanie Boltzmann, PhD  ·  +49 5152781256  ·  m.boltzmann@bdh-klinik-hessisch-oldendorf.de

Simone B. Jenner  ·  +49 5152781215  ·  s.jenner@bdh-klinik-hessisch-oldendorf.de

Always discuss trial participation with your own doctor first.

Locations (1)

BDH-Klinik Hessisch OldendorfHessisch Oldendorf, Lower Saxony, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07456020